The 2025-2030 World Outlook for Surgical Sutures

The 2025-2030 World Outlook for Surgical Sutures

This study covers the world outlook for surgical sutures across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

In this report we define the sales of surgical sutures as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include 3M Company, AD Surgical, Aesculap, AJT Holdings, Angiotech Pharmaceuticals, Apollo Endosurgery, Arlington Capital Partners, Atramat, B. Braun, Bioline Fios Cirúrgicos, Ltd.a, Boston Scientific, Braun Melsungen, BSN Medical, Coloplast, CONMED Corporation, Covidien, CP Medical, Demetech, Dextera Surgical, Endoevolution, Enterprise Florida, Inc., Ethicon, Eurazeo SA, France Stratégie, FSSB Chirurgische Nadein GmbH, General Electric, Health Metrics, Informa UK, Ltd., Integra LifeSciences, Internacional FarmaceutiCA, Johnson & Johnson, Medline Industries, Medtronic, Mellon Medical, Meril Life Sciences, Molnlycke healthcare, Nuvo Medsurg Pvt, Ltd., Peters Surgical, Péters Surgical, PFM Medical, Politexmed, LLC, Premier, Real College of Surgeons, Riverpoint Medical, Shandong Weixin Medical Device Company, Shanghai Fosun Medical System Co., Ltd (Fosun), Singapore Medical Centre, SMI AG, Stericat Gutstrings Pvt, Ltd., Stryker, Surgical Specialties, Sutures India, TachoSil Fibrin Sealant Patch, Tagumedica SA, Takeda Pharmaceutical, Tan Teck Kee, Teleflex, Theragenics, Touch Surgery, Troge Medical, Uniplex UK, Ltd., Vectec SA, Vitalitec, W. L. Gore & Associates, Weigao Holding Company, Weihai Weigao Blood Supplier Company, Ltd., Wellford Capital, Ltd., Zimmer Biomet, and Zurich Medical Corp Banking Corporation. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).